These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ion channels and arrhythmias]. Borchard U; Hafner D Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780 [TBL] [Abstract][Full Text] [Related]
3. Perspectives on the current treatment of cardiac arrhythmias. Bigger JT Am J Cardiol; 1984 Aug; 54(4):2B-7B. PubMed ID: 6147081 [TBL] [Abstract][Full Text] [Related]
4. Drugs for cardiac arrhythmias. Treat Guidel Med Lett; 2007 Jun; 5(58):51-8. PubMed ID: 17505408 [No Abstract] [Full Text] [Related]
6. Antiarrhythmic drugs: electrophysiological basis of their clinical usage. Weng JT; Smith DE; Moulder PV Ann Thorac Surg; 1986 Jan; 41(1):106-12. PubMed ID: 2417568 [TBL] [Abstract][Full Text] [Related]
7. Drugs for cardiac arrhythmias. Med Lett Drugs Ther; 1989 Apr; 31(790):35-40. PubMed ID: 2565011 [No Abstract] [Full Text] [Related]
8. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis. Chay TR J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110 [TBL] [Abstract][Full Text] [Related]
9. [Current classification of anti-arrhythmia agents]. Weirich J; Wenzel W Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787 [TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of antiarrhythmic therapy. Roden DM N Engl J Med; 1994 Sep; 331(12):785-91. PubMed ID: 8065408 [No Abstract] [Full Text] [Related]
11. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade. Skanes AC; Morton BC; Green MS; Tang AS Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970 [TBL] [Abstract][Full Text] [Related]
12. Drugs for cardiac arrhythmias. Med Lett Drugs Ther; 1991 Jun; 33(846):55-60. PubMed ID: 1674978 [No Abstract] [Full Text] [Related]
13. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
14. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates. Roden DM Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs. Singh BN; Wadhani N J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S85-97. PubMed ID: 15378133 [TBL] [Abstract][Full Text] [Related]
16. [Calcium antagonists: sites of action, pharmacologic effect profile and clinical use. 2: Pharmacologic effects, indications and side effects of calcium antagonists]. Bluth R; Langnickel R Z Arztl Fortbild (Jena); 1986; 80(6):237-40. PubMed ID: 2424182 [No Abstract] [Full Text] [Related]
19. Antiarrhythmic agents: current status and perspectives. Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860 [No Abstract] [Full Text] [Related]
20. Sodium channel blockers in the treatment of ventricular arrhythmias: different effects in the normal, ischaemic or failing heart? Haverkamp W; Hindricks G; Fechtrup C; Borggrefe M; Breithardt G Eur Heart J; 1991 Dec; 12 Suppl F():10-7. PubMed ID: 1666550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]